Use in the EP lab
Iodinated contrast opacifies vessels under fluoroscopy. In the EP lab it’s used for:
- Venography to define axillary/subclavian/cephalic anatomy before lead access, and to map the coronary sinus and its tributaries for CRT lead placement
- Angiography of chambers or great vessels when needed during ablation or device work
- Occasional aortography/RAO-LAO road-mapping for specific access
Volumes are typically small compared with the cath lab — a few milliliters of diluted contrast for a venogram often suffices.
Agents
Modern contrast is non-ionic, low- or iso-osmolar (e.g., iohexol, iodixanol). These supplanted the older high-osmolar ionic agents and have a much better safety profile, but renal and hypersensitivity risks remain.
Renal risk
- Contrast-associated AKI is dose- and risk-dependent — worse with low eGFR, diabetes, heart failure, volume depletion, and large contrast loads
- Mitigation: assess eGFR, ensure euvolemia/hydration, hold nephrotoxins where feasible, and minimize volume (dilute for venography)
- Metformin: not nephrotoxic itself, but continued metformin in a patient who develops contrast AKI risks lactic acidosis — follow institutional hold/recheck policy in low-eGFR patients
Hypersensitivity reactions
- Range from mild (urticaria, flushing) to severe anaphylactoid reactions — most are not true IgE-mediated allergy
- Premedicate known prior reactors: a corticosteroid regimen (e.g., prednisone at 13, 7, and 1 h pre, or IV hydrocortisone if urgent) plus an antihistamine
- A prior reaction to contrast is the meaningful risk factor — “shellfish/iodine allergy” does not predict contrast reactions and should not drive decisions
- Acute management of a reaction is covered in the contrast reaction entry — know where the epinephrine and the reaction protocol are before you inject
Common pitfalls
- Withholding contrast for a “shellfish allergy” — not evidence-based.
- Skipping premedication in a documented prior reactor.
- Using undiluted, high-volume contrast for a simple venogram in a CKD patient.
- Forgetting the metformin question in low-eGFR patients.